Incannex Healthcare (IXHL) Profit After Tax (2022 - 2026)

Incannex Healthcare (IXHL) posted quarterly Profit After Tax of -$4.4 million for Q1 2026, down 7.27% year-on-year from -$4.7 million in Q1 2025, and up 33.28% on a QoQ basis from -$6.5 million in Q4 2025.

Incannex Healthcare (IXHL) Profit After Tax (2022 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Profit After Tax for 5 consecutive years, with -$4.4 million the latest figure, recorded in Q1 2026.

  • Quarterly Profit After Tax fell 7.27% year-over-year to -$4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.7 million (down 126.55% YoY) and the FY2025 annual result came in at -$46.9 million, down 152.94% from the prior year.
  • Profit After Tax grew to -$4.4 million in Q1 2026 per IXHL's latest filing, from -$6.5 million in the prior quarter.
  • Over the last five years, Profit After Tax for IXHL reached as high as -$1.2 million in Q3 2023 and fell as low as -$31.4 million in Q2 2025.
  • A 5-year average of -$7.0 million and a median of -$5.7 million in 2024 frame the typical range for Profit After Tax.
  • The largest YoY upside for Profit After Tax was 40.8% in 2025 against a maximum downside of 412.47% in 2025.
  • Year by year, Profit After Tax stood at -$2.9 million in 2022, then tumbled by 79.61% to -$5.2 million in 2023, then declined by 12.46% to -$5.9 million in 2024, then retreated by 10.64% to -$6.5 million in 2025, then soared by 33.28% to -$4.4 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$4.4 million, -$6.5 million, and -$6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 369.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.35 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - -4.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.35 Mn
Dec 31, 2025 -6.52 Mn
Sep 30, 2025 -6.41 Mn
Jun 30, 2025 -31.44 Mn
Mar 31, 2025 -4.06 Mn
Dec 31, 2024 -5.89 Mn
Sep 30, 2024 -5.42 Mn
Jun 30, 2024 -6.14 Mn
Mar 31, 2024 -6.85 Mn
Dec 31, 2023 -5.24 Mn
Sep 30, 2023 -1.24 Mn
Jun 30, 2023 -7.75 Mn
Mar 31, 2023 -3.77 Mn
Dec 31, 2022 -2.92 Mn